All News #Library
Rare Diseases
Rein Therapeutics Initiates Phase 2 Trial For LTI-03
03 Mar 2026 //
GLOBENEWSWIRE
Rein Therapeutics Gets EMA Orphan Drug Status For IPF Candidate
20 Jan 2026 //
GLOBENEWSWIRE
Rein Therapeutics Gets EU Approval To Initiate LTI-03 Ph2 Trial
09 Oct 2025 //
GLOBENEWSWIRE
Rein Publishes Translational Data on IPF Novel Therapy
17 Sep 2025 //
GLOBENEWSWIRE
Rein Therapeutics Begins RENEW Phase 2 Trial of LTI-03 in IPF
27 May 2025 //
PR NEWSWIRE

Market Place
Sourcing Support